Clinical Trials on Deep Venous Thromboses in Canada

Total 427 results

Ottawa Hospital Research Institute
University of Alberta; Hamilton Health Sciences Corporation; Queen Elizabeth...

Completed

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines (TRIM-Line)

Cancer | Central Venous Catheter Thrombosis | Upper Extremity Deep Vein Thrombosis

Canada
Ottawa Hospital Research Institute

Terminated

Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation (SPADE)

Deep Vein Thrombosis | Venous Thromboembolism

Canada
Michael Kovacs
Ottawa Hospital Research Institute; Jewish General Hospital

Recruiting

Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients

Cancer Patients | Central Venous Catheter Thrombosis | Upper Extremity Thrombosis

Canada
Lakehead University
Northern Ontario School of Medicine

Completed

Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial

Osteoarthritis | Deep Venous Thrombosis

Canada
London Health Sciences Centre

Completed

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Central Venous Catheter Thrombosis | Neoplasm

Canada
Dr. Kerstin de Wit
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Recruiting

Improving Emergency Department Testing for Deep Vein Thrombosis

Deep Vein Thrombosis (DVT)

Canada
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study (4D)

Suspected Deep Vein Thrombosis

Canada
Nova Scotia Health Authority

Completed

Osteopathic Treatment and Deep Vein Thrombosis (DVT)

Deep Vein Thrombosis (DVT)

Canada
Ottawa Hospital Research Institute
The Ottawa Hospital Academic Medical Association

Withdrawn

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep-Vein Thrombosis

Canada
Hamilton Health Sciences Corporation
Health Canada

Completed

D-Dimer Vs Serial Compression Ultrasound Study

Deep Vein Thrombosis

Canada
University Hospital, Geneva
Canadian Institutes of Health Research (CIHR); Ministry of Health, France; Swiss... and other collaborators

Completed

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT) (CACTUS-PTS)

Distal (Calf) Deep-vein Thrombosis

Canada, Switzerland, France
Dr. Vicky Tagalakis
Sanofi

Terminated

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots (STEP-CAT)

Deep Vein Thrombosis

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Deep Vein Thrombosis

Canada
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
Bayer
Janssen Research & Development, LLC

Completed

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

Venous Thrombosis | Deep Vein Thrombosis

Switzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
Bayer

Recruiting

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis (SIRIUS)

Thrombolysis | Symptomatic Proximal Deep Vein Thrombosis

Belgium, France, Italy, Netherlands, Canada, Germany, Czechia
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

MDA D-Dimer / Recurrent DVT Study

Deep Vein Thrombosis

Netherlands, Canada
Daiichi Sankyo, Inc.

Completed

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

Deep Vein Thrombosis | Venous Thromboembolism

Spain, United States, United Kingdom, India, France, Canada, Italy, Lebanon, Turkey
Agen Biomedical

Completed

Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis

Deep Vein Thrombosis

United States, Canada
McMaster University
Heart and Stroke Foundation of Ontario

Completed

Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT) (SELECT)

Deep Vein Thrombosis

Canada
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Ontario

Completed

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism (REMARK)

Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep-Vein Thrombosis

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation... and other collaborators

Unknown

Understanding Risk Factors Involved in Developing a Second Blood Clot.

Deep Vein Thrombosis

Canada, France
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada
Daiichi Sankyo, Inc.

Completed

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Pulmonary Embolism | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT)

United States, Israel, Spain, Czechia, Singapore, Canada, Argentina, Brazil, Bulgaria, Chile, Croatia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Kenya, Korea, Republic of, Lebanon, Malaysia, Netherlands, Norway, ... and more
Ottawa Hospital Research Institute
University Hospital, Geneva; Leiden University Medical Center

Unknown

Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer (LEaD)

Pregnancy | Deep Vein Thrombosis

Netherlands, Canada, Switzerland, United States
Queen's University
The Physicians' Services Incorporated Foundation

Completed

Limited Compression Ultrasound by Emergency Physicians to Exclude Deep Vein Thrombosis

Deep Vein Thrombosis

Canada
Leiden University Medical Center
Trombosestichting Nederland

Completed

Advanced Diagnostic Management of Suspected Recurrent Ipsilateral DVT With MRDTI (Theia)

Deep Vein Thrombosis

Netherlands, Sweden, Canada, Israel, Norway
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Venous Thromboembolism

France, Italy, Czech Republic, Canada, Netherlands, Australia, United States, Poland, South Africa, Sweden, Israel, Denmark, Brazil
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); Canadian Critical Care Trials...

Completed

PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)

Critically Ill | Deep Venous Thrombosis

Canada, Australia
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Terminated

Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)

Deep Venous Thrombosis | Suspected Pulmonary Embolism

Canada
University Hospital, Geneva
University Medical Center Groningen; The Ottawa Hospital

Unknown

Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study (ADJUST-DVT)

Deep Vein Thrombosis | D-dimer

Canada, Switzerland, France
University of Alberta
Vancouver Coastal Health Research Institute

Completed

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

Atrial Fibrillation | Thromboembolism | Deep Venous Thrombosis | DVT | Thrombus Due to Heart Valve Prosthesis

Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton

Unknown

Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) (ROCITP2)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute

Completed

Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism (SOME)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada
Sunnybrook Health Sciences Centre
LEO Pharma; Sunnybrook Research Institute

Terminated

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (TILE)

Deep Vein Thrombosis | Post Thrombotic Syndrome

Canada
Oslo University Hospital
Vestre Viken Hospital Trust; McMaster University; Ostfold Hospital Trust; Sahlgrenska... and other collaborators

Completed

Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran (DABI-PTS)

Postthrombotic Syndrome

Norway, Canada, Sweden
Diagnostica Stago
University Hospital, Grenoble

Completed

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism (DiET)

Pulmonary Embolism | Deep Venous Thrombosis | D-dimer

United States, France, Canada, Italy, Spain
McMaster University
Heart and Stroke Foundation of Ontario

Completed

Fixed Dose Heparin Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada, New Zealand
McMaster University
Canadian Institutes of Health Research (CIHR); Australian and New Zealand Intensive... and other collaborators

Completed

PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)

Critical Illness | Deep Venous Thrombosis

United States, Australia, Canada, Saudi Arabia, Brazil, United Kingdom
Daiichi Sankyo, Inc.

Completed

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (eTRIS)

Venous Thrombosis | Deep Vein Thrombosis

United States, Canada
Sir Mortimer B. Davis - Jewish General Hospital
Canadian Institutes of Health Research (CIHR); Sigvaris Corporation

Completed

The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome

Deep Venous Thrombosis

United States, Canada
Kevin H.M. Kuo, MD, MSc, FRCPC

Recruiting

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) (THIS)

Sickle Cell Disease | Venous Thromboembolism | Central Venous Catheter Thrombosis

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
Sir Mortimer B. Davis - Jewish General Hospital
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation... and other collaborators

Completed

Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial (Bio-SOX)

Deep Venous Thrombosis

United States, Canada
Daiichi Sankyo, Inc.

Completed

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

France, United States, Japan, Denmark, Italy, Russian Federation, Czechia, Germany, India, Israel, Philippines, Taiwan, Ukraine, Australia, Austria, China, Argentina, Belarus, Belgium, Brazil, Canada, Chile, Estonia, Hungary, Korea, Republic... and more
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Terminated

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Deep Vein Thrombosis | Pulmonary Embolism

Canada, Italy
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Latvia, Ireland, Germany, United Kingdom, Canada, Norway, Sweden, Czechia, Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain

Clinical Trials on Deep Venous Thromboses in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations